perspectives
Stop the insanity: If you’re a marketer and have never heard of Twitter or Facebook you’re living in a fanstasy world
Also being one to never hold back what I am thinking I want to take a step further. Here are the reason that there are so many conferences and why the same information is presented again and again.
Read the full storyIf You Can’t Beat the Regulators, Sic ‘Em on Your Competition!
In his latest post to DTC Perspectives Blog, Chairman Bob Ehrlich suggests that the Congress should regulate all health advertising and not just single out Direct-to-Consumer (DTC) advertising by drug companies (see ” The Inequality of DTC Regulation “).
Read the full storyThe Economy, Patent Cliffs and Funding¦What™s a Pharmaco to do?
This week’s submission of ’52 Perspectives’ comes to us from Kurt Vorheis, Principal at V2 Bio-Consulting, Inc., a specialized consulting business providing operational expertise to BioPharma, Chemical, and Industrial companies. 1. Given the current state of the economy, what steps do you think are necessary for pharmaceutical companies to take with regard to outsourcing?
Read the full story52 Perspectives: œWell defined Preclinical Trial models
This week’s submission of “52 Perspectives” comes to us from Kevin Baker. Kevin is the co-founder of External Pharma, a leading provider of preclinical and drug discovery services and currently serves as director of service and strategic development
Pharma Agency Awards for Web 1.0, None for Blogs or Other Social Media
There were two major awards events in the past week. The first was the 2009 DTC National Advertising Awards presented by DTC Perspectives Magazine at the conference of the same name held in Washington, DC on April 15 to 17 (see results here ). The second was the Manny Awards presented by Med Ad News on April 22 (see press release here )
Read the full story




